Polyphron raises $20M
Polyphron announced a Seed round of $20M on 24 September 2026. The company operates in HealthTech and is based in United States. It was founded by Matthew Osman, Co-founder & CEO. Announced today.
Founder
Matthew Osman
Co-founder & CEO, Polyphron
Outreach angles
- -Matthew Osman co-founded Polyphron with Fabio Boniolo, who previously worked at Dana-Farber Cancer Institute, the Broad Institute and Harvard Medical School.
- -Osman's team also includes Vinh Q. Tran, who previously worked on post-training research for Gemini at Google DeepMind, and COO George Pilitsis, who scaled the Datapoints line at Ginkgo Bioworks.
- -The new 20 million dollar seed round, led by Quiet Capital, will fund Polyphron's New York lab as it builds living human tissue models, with cardiac tissue already in production and liver tissue slated for 2026.
Signals
SeedDeep TechHealthcareAI-NativeB2B
Round details
Company: Polyphron
Domain: polyphron.com
Amount: $20M
Stage: Seed
Industry: HealthTech
Country: United States
Announced: 24 September 2026
Other HealthTech raises
Recently funded in United States